Tango Therapeutics, INC Form 4 insider transactions

Lesley Ann Calhoun, a director at Tango Therapeutics, reported the acquisition and disposal of common stock and stock options.

Director John B Ketchum reports acquiring shares and stock options in Tango Therapeutics, Inc.

Director Alexis Borisy reports acquisition of common stock and stock options in Tango Therapeutics.

MVA Investors, LLC, and Aaron I. Davis, reported selling shares of Tango Therapeutics, Inc. (TNGX) between May 1 and May 3, 2024.